Pricing Log in Create free account

Avalo Therapeutics, Inc. (AVTX) vs WAVE Life Sciences Ltd. (WVE)

Avalo Therapeutics, Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Avalo Therapeutics, Inc. and WAVE Life Sciences Ltd. are of similar size ($644.1M and $628.6M). WAVE Life Sciences Ltd. grew revenue faster over the last twelve months: −30.4% against −92.7%. Avalo Therapeutics, Inc. has the higher net margin (0.00% vs −309.7%) and the lower return on invested capital (−118.2% vs 0.00%). Across the 17 metrics below, Avalo Therapeutics, Inc. leads on 10 and WAVE Life Sciences Ltd. on 7.

Valuation

Metric AVTX WVE Biotechnology median
P/E n/m n/m 8.50
P/S 394.06 9.74 9.71
P/B 1.10 1.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 82.27 2.23 9.21
Earnings yield (38.78%) (34.94%) (33.15%)
Free cash flow yield (28.32%) (30.34%) (25.50%)

Profitability

Metric AVTX WVE Biotechnology median
Gross margin 64.72% 100.00% 65.16%
Operating margin 0.00% (333.36%) 0.00%
Net margin 0.00% (309.73%) 0.00%
Free cash flow margin 0.00% (295.46%) 0.00%
Return on equity (36.27%) (68.31%) (56.36%)
Return on assets (32.50%) (49.95%) (48.04%)
Return on invested capital (118.21%) 0.00% 0.00%

Growth

Metric AVTX WVE Biotechnology median
Revenue growth (TTM) (92.65%) (30.42%) 6.02%
EPS growth (last fiscal year) (24.62%) (72.86%) 30.26%
Revenue growth, 5-year CAGR (61.19%) 16.31% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVTX WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.31 9.99 4.72
Net debt to EBITDA 1.36 2.92 0.96

Dividend

Metric AVTX WVE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AVTX WVE Biotechnology median
Market cap 644.10m 628.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack